Does use of nonsteroidal anti-inflammatory drugs increase patients’ clinical severity of COVID-19?

Author:

de Oliveira Henrique Souza Barros1ORCID

Affiliation:

1. Centro Universitário São Camilo, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Reference5 articles.

1. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study;Drake TM;Lancet Rheumatol,2021

2. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists;Day M.;BMJ,2020

3. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts;Wong AY;Ann Rheum Dis,2021

4. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study;Lund LC;PLoS Med,2020

5. Prescrição inadequada de medicamentos a idosos portadores de doenças crônicas em um plano de saúde no município de São Paulo, Brasil [Inappropriate medication use in older adults with chronic diseases in a health plan in São Paulo, Brazil];Manso MEG;Rev Bras Geriatr Gerontol,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3